EUVIMEDEUVIMED entdecken
Crossref

RGS1 Modulates Autophagic and Metabolic Programs and Is a Critical Mediator of Human Regulatory T Cell Function

Alyssa L Flynn iD, Joseph Gans, Javier Escobedo, Cheng Zhu, Ana-Maria Florescu, Srinivas Shankara iD, Stephen L Madden, Peter S Kim, Lily I Pao iD

The Journal of Immunology · 2023

DOI: 10.4049/jimmunol.2200402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von Alyssa L Flynn und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Sanofi, Cambridge, MA. Hauptthemen laut MEDLINE: Autoimmune Diseases, Neoplasms, RGS Proteins. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regulatory T cells (Tregs) are critical mediators of immune tolerance and play a diametric role in cancer and autoimmunity. Tumor-infiltrating Tregs are often associated with poor prognosis in solid tumors because their enrichment in the tumor microenvironment contributes to immunosuppression. Conversely, dysregulation in the Treg compartment can disrupt self-tolerance, leading to autoimmunity. In the present study, we describe what is, to our knowledge, a novel regulator of Tregs, the GTPase activator regulator of G protein 1 (RGS1), demonstrating that RGS1-deficient human Tregs show downregulation of Treg-associated genes and are less immunosuppressive. These RGS1-deficient Tregs exhibit perturbations to the FOXP3–c-MYC transcriptional axis and downstream metabolic and autophagy programs by shifting their energy demands toward glycolysis and rendering them less autophagic. Taken together, RGS1 may serve as an apical node of Treg function by regulating the FOXP3–c-MYC transcriptional axis, thereby providing a therapeutic rationale for targeting RGS1 for treatment of cancer and autoimmune diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune DiseasesNeoplasmsRGS ProteinsHumansT-Lymphocytes, RegulatoryAutoimmunityAutophagyForkhead Transcription FactorsTumor Microenvironment

Substanzen

Forkhead Transcription FactorsRGS1 protein, humanRGS Proteins

Autor:innen und Institutionen

  • Department of Oncology, Sanofi, Cambridge, MA.
  • Department of Translational Sciences, Sanofi, Cambridge, MA.
  • Department of Precision Oncology, Sanofi, Vitry-sur-Seine, France.

ORCID-Profile: Alyssa L Flynn, Srinivas Shankara, Lily I Pao

Zitieren

APA

Flynn, A. L., Gans, J., Escobedo, J., Zhu, C., Florescu, A. M., Shankara, S., Madden, S. L., Kim, P. S., & Pao, L. I. (2023). RGS1 Modulates Autophagic and Metabolic Programs and Is a Critical Mediator of Human Regulatory T Cell Function. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2200402

Vancouver

Flynn AL, Gans J, Escobedo J, Zhu C, Florescu AM, Shankara S, et al. RGS1 Modulates Autophagic and Metabolic Programs and Is a Critical Mediator of Human Regulatory T Cell Function. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2200402

BibTeX
@article{Flynn2023,
  author = {Flynn, Alyssa L and Gans, Joseph and Escobedo, Javier and Zhu, Cheng and Florescu, Ana-Maria and Shankara, Srinivas and Madden, Stephen L and Kim, Peter S and Pao, Lily I},
  title = {RGS1 Modulates Autophagic and Metabolic Programs and Is a Critical Mediator of Human Regulatory T Cell Function},
  journal = {The Journal of Immunology},
  year = {2023},
  doi = {10.4049/jimmunol.2200402}
}
Kostenlos starten →